PQ 231
234 Deputy Dan Neville asked the Minister for Health if the Vertex created kayldeco drug for people with cystic fibrosis, with the G155D mutation, is available through the health services under the long-term illness scheme. [32540/12]
Introduced
4 July 2012
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
4 July 2012
Summary
234 Deputy Dan Neville asked the Minister for Health if the Vertex created kayldeco drug for people with cystic fibrosis, with the G155D mutation, is available through the health services under the long-term illness scheme. [32540/12]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 4 July 2012
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2012-07-04/231/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2012-07-04/pq_231